An endothelin receptor (ETA) antagonist isolated from Streptomyces misakiensis.
M Ihara, T Fukuroda, T Saeki, M Nishikibe, K Kojiri, H Suda, M Yano
Index: Biochem. Biophys. Res. Commun. 178 , 132, (1991)
Full Text: HTML
Abstract
A competitive endothelin (ET) antagonist, BE-18257B, was isolated from the fermentation products of Streptomyces misakiensis. It is a novel cyclic pentapeptide, cyclo(-D-Glu-L-Ala-allo-D-Ile-L-Leu-D-Trp-), and binds to ETA receptors (ET-1 selective) in cardiovascular tissues, but not to ETB receptors (equally sensitive to isopeptides of ET family) in kidney, adrenal gland and cerebellum tissues. BE-18257B also antagonizes ET-1-induced vasoconstriction in rabbit iliac artery and pressor action in rats. Thus it is a selective ETA antagonist and should provide a valuable tool for elucidation of the pharmacological and pathophysiological roles of ET-1.
Related Compounds
Related Articles:
1993-08-01
[Tanpakushitsu Kakusan Koso. 38(11) , 1827-40, (1993)]
1995-11-01
[Circulation 92(9 Suppl) , II400-4, (1995)]
1994-02-01
[Br. J. Pharmacol. 111(2) , 473-82, (1994)]
1993-09-03
[J. Med. Chem. 36(18) , 2658-65, (1993)]
1991-12-01
[J. Antibiot. 44(12) , 1342-7, (1991)]